You are here: Home » Reuters » News
Business Standard

EU officials clash with Chinese firm on drug factory inspection

Reuters  |  LONDON 

By Ben HirschlerLONDON (Reuters) - European medicines regulators have issued a notice that an ingredient for a generic brain cancer drug made in China does not meet manufacturing standards, after inspectors were refused entry to a factory run by Jiangsu Yew Pharmaceutical Co. Ltd.The incident, reported in a notice published this week on a database maintained by the European Medicines Agency, is the latest example of regulatory problems with bulk pharmaceutical substances manufactured in China.It follows a scandal over tainted supplies of the widely used heart drug valsartan from Zhejiang ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, September 12 2018. 21:47 IST
RECOMMENDED FOR YOU